Halozyme Therapeutics (HALO) PT Raised to $58 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Mohit Bansal raised the price target on Halozyme Therapeutics (NASDAQ: HALO) to $58.00 (from $48.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
